# Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer

> **NCT00690300** · PHASE2 · UNKNOWN · sponsor: **University of Ulm** · enrollment: 44 (estimated)

## Conditions studied

- Pancreas Neoplasms

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT00690300
- **Lead sponsor:** University of Ulm
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-01
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2010-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00690300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00690300, "Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT00690300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*